Baird Medical Investment Holdings Ltd
About Baird Medical Investment Holdings Ltd
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $22.5M
- Net income
- -$27.3M
- Total assets
- $69.7M
- Market cap
- $40.3M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $40.3M
- Shares outstanding
- 31.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 2, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $27.3M in FY2025.
- Trading 82% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Baird Medical Investment Holdings Ltd.
